Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 11 | $641,940 |
| Sells | 76 | $6,028,916 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 19 Mar 2025 16:32 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 17 Mar 2025 | Sale | 1,784 | 10.67 | 19,035 | D |
| 12 Dec 2024 17:00 | TRDA | Entrada Therapeutics Inc | MPM BIOVENTURES 2018, L.P. | 10% | 10 Dec 2024 | Sale | 22,935 | 20.77 | 476,360 | I |
| 12 Dec 2024 17:00 | TRDA | Entrada Therapeutics Inc | MPM BIOVENTURES 2018, L.P. | 10% | 11 Dec 2024 | Sale | 21,787 | 20.23 | 440,751 | I |
| 12 Dec 2024 17:00 | TRDA | Entrada Therapeutics Inc | MPM BIOVENTURES 2014, L.P. | 10% | 10 Dec 2024 | Sale | 22,935 | 20.77 | 476,360 | I |
| 12 Dec 2024 17:00 | TRDA | Entrada Therapeutics Inc | MPM BIOVENTURES 2014, L.P. | 10% | 11 Dec 2024 | Sale | 21,787 | 20.23 | 440,751 | I |
| 03 Dec 2024 17:26 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 29 Nov 2024 | Sale | 1,000 | 19.9703 | 19,970 | D |
| 03 Dec 2024 17:26 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 02 Dec 2024 | Sale | 5,000 | 19.9956 | 99,978 | D |
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 29 Nov 2024 | Sale | 100 | 20 | 2,000 | D |
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 02 Dec 2024 | Sale | 4,088 | 20.2626 | 82,834 | D |
| 03 Dec 2024 17:24 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 03 Dec 2024 | Sale | 11,703 | 20.1475 | 235,786 | D |
| 13 Nov 2024 16:49 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 11 Nov 2024 | Sale | 1,409 | 20.0079 | 28,191 | D |
| 13 Nov 2024 16:49 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 13 Nov 2024 | Sale | 2,700 | 20.0403 | 54,109 | D |
| 13 Nov 2024 16:47 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 11 Nov 2024 | Sale | 8,637 | 19.9794 | 172,562 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 04 Nov 2024 | Sale | 749 | 18.022 | 13,498 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 05 Nov 2024 | Sale | 5,171 | 18.1795 | 94,006 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 06 Nov 2024 | Sale | 9,554 | 18.7097 | 178,752 | D |
| 06 Nov 2024 16:36 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 06 Nov 2024 | Sale | 2,745 | 19.3164 | 53,024 | D |
| 18 Oct 2024 16:31 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | President, Research & Develop. | 16 Oct 2024 | Sale | 600 | 18 | 10,800 | D |
| 30 Sep 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 26 Sep 2024 | Sale | 847 | 16 | 13,552 | D |
| 10 Sep 2024 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 09 Sep 2024 | Sale | 3,195 | 14.971 | 47,832 | D |
| 10 Sep 2024 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 09 Sep 2024 | Sale | 1,904 | 15.0684 | 28,690 | D |
| 10 Sep 2024 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 06 Sep 2024 | Sale | 399 | 15.1947 | 6,063 | D |
| 10 Sep 2024 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 09 Sep 2024 | Sale | 2,642 | 15.0879 | 39,862 | D |
| 10 Sep 2024 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 06 Sep 2024 | Sale | 600 | 15.2356 | 9,141 | D |
| 20 Aug 2024 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 16 Aug 2024 | Sale | 502 | 16.698 | 8,382 | D |
| 20 Aug 2024 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 16 Aug 2024 | Sale | 26,595 | 16.2594 | 432,419 | D |
| 16 Jul 2024 16:43 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 15 Jul 2024 | Sale | 638 | 18 | 11,484 | D |
| 16 Jul 2024 16:43 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 12 Jul 2024 | Sale | 600 | 18 | 10,800 | D |
| 16 Jul 2024 16:42 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 12 Jul 2024 | Sale | 300 | 18 | 5,400 | D |
| 16 Jul 2024 16:42 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 15 Jul 2024 | Sale | 1,600 | 17.8108 | 28,497 | D |
| 10 Jul 2024 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 08 Jul 2024 | Sale | 1,758 | 14.95 | 26,282 | D |
| 14 Jun 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 13 Jun 2024 | Sale | 1,000 | 16.1736 | 16,174 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 20 May 2024 | Sale | 9,675 | 15.188 | 146,944 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 May 2024 | Sale | 8,305 | 15.1416 | 125,751 | D |
| 20 May 2024 17:26 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 16 May 2024 | Sale | 1,000 | 15 | 15,000 | D |
| 20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 17 May 2024 | Sale | 1,200 | 15.1076 | 18,129 | D |
| 20 May 2024 17:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 May 2024 | Sale | 1,800 | 15 | 27,000 | D |
| 16 May 2024 16:33 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 14 May 2024 | Purchase | 25,000 | 14.5869 | 364,672 | D |
| 10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 09 May 2024 | Purchase | 2,200 | 14.2459 | 31,341 | D |
| 10 May 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 May 2024 | Purchase | 2,276 | 14.0442 | 31,965 | D |
| 10 Apr 2024 16:35 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 08 Apr 2024 | Purchase | 2,600 | 13.573 | 35,290 | D |
| 01 Apr 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 28 Mar 2024 | Purchase | 1,512 | 13.7526 | 20,794 | D |
| 26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 26 Mar 2024 | Purchase | 2,750 | 13.6397 | 37,509 | D |
| 26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 25 Mar 2024 | Purchase | 3,180 | 13.356 | 42,472 | D |
| 26 Mar 2024 17:57 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 22 Mar 2024 | Purchase | 3,118 | 13.759 | 42,901 | D |
| 21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 21 Mar 2024 | Purchase | 704 | 13.2353 | 9,318 | D |
| 21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 20 Mar 2024 | Purchase | 1,128 | 12.6604 | 14,281 | D |
| 21 Mar 2024 16:31 | TRDA | Entrada Therapeutics Inc | KIM PETER S | Director | 19 Mar 2024 | Purchase | 900 | 12.6633 | 11,397 | D |
| 08 Mar 2024 16:36 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Mar 2024 | Sale | 4,086 | 12.3067 | 50,285 | D |
| 08 Mar 2024 16:34 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | President & COO | 06 Mar 2024 | Sale | 1,826 | 12.3213 | 22,499 | D |
| 20 Feb 2024 16:37 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 15 Feb 2024 | Sale | 1,000 | 15 | 15,000 | D |
| 18 Jan 2024 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | CEO | 16 Jan 2024 | Sale | 1,000 | 15.99 | 15,990 | D |
| 26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 26 Dec 2023 | Sale | 94 | 16.67 | 1,567 | D |
| 26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 3,677 | 16.4837 | 60,611 | D |
| 26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 22 Dec 2023 | Sale | 6,529 | 15.2417 | 99,513 | D |
| 26 Dec 2023 16:35 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Dec 2023 | Sale | 2,200 | 15.0703 | 33,155 | D |
| 22 Dec 2023 16:38 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 20 Dec 2023 | Sale | 1,000 | 15 | 15,000 | D |
| 13 Nov 2023 16:35 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Nov 2023 | Sale | 1,000 | 16.23 | 16,230 | D |
| 19 Oct 2023 17:27 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 17 Oct 2023 | Sale | 1,000 | 15 | 15,000 | D |
| 15 Sep 2023 16:21 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 13 Sep 2023 | Sale | 1,000 | 15 | 15,000 | D |
| 06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 46 | 14.03 | 645 | D |
| 06 Sep 2023 17:11 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 06 Sep 2023 | Sale | 904 | 13.4522 | 12,161 | D |
| 06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 21 | 14 | 294 | D |
| 06 Sep 2023 17:08 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 06 Sep 2023 | Sale | 871 | 13.4647 | 11,728 | D |
| 06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 59 | 14.0069 | 826 | D |
| 06 Sep 2023 17:07 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 06 Sep 2023 | Sale | 913 | 13.4312 | 12,263 | D |
| 16 Aug 2023 16:32 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 14 Aug 2023 | Sale | 1,000 | 15.6713 | 15,671 | D |
| 04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 04 Aug 2023 | Sale | 6,898 | 14.1376 | 97,521 | D |
| 04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 03 Aug 2023 | Sale | 9,464 | 14.7432 | 139,530 | D |
| 04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 68 | 16.82 | 1,144 | D |
| 04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 1,000 | 16.0117 | 16,012 | D |
| 04 Aug 2023 16:50 | TRDA | Entrada Therapeutics Inc | KREHER NERISSA | Chief Medical Officer | 02 Aug 2023 | Sale | 9,280 | 15.0876 | 140,013 | D |
| 12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 11 Jul 2023 | Sale | 3,884 | 17.9979 | 69,904 | D |
| 12 Jul 2023 16:34 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 10 Jul 2023 | Sale | 6,116 | 17.9788 | 109,958 | D |
| 12 Jul 2023 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 11 Jul 2023 | Sale | 3,897 | 18.048 | 70,333 | D |
| 12 Jul 2023 16:33 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 10 Jul 2023 | Sale | 3,200 | 18.0016 | 57,605 | D |
| 12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 11 Jul 2023 | Sale | 14,852 | 18.039 | 267,915 | D |
| 12 Jul 2023 16:32 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 10 Jul 2023 | Sale | 3,026 | 18.002 | 54,474 | D |
| 23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,907 | 15.1711 | 135,129 | D |
| 23 Jun 2023 16:20 | TRDA | Entrada Therapeutics Inc | WENTWORTH KORY JAMES | Chief Financial Officer | 21 Jun 2023 | Sale | 8,593 | 14.8399 | 127,519 | D |
| 22 Jun 2023 16:46 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 22 Jun 2023 | Sale | 7,097 | 16.0208 | 113,700 | D |
| 22 Jun 2023 16:46 | TRDA | Entrada Therapeutics Inc | DOWDEN NATHAN J | Chief Operating Officer | 20 Jun 2023 | Sale | 8,885 | 14.9357 | 132,704 | D |
| 01 May 2023 16:38 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Apr 2023 | Sale | 2,000 | 13.7109 | 27,422 | D |
| 19 Apr 2023 18:07 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 17 Apr 2023 | Sale | 2,092 | 18.0092 | 37,675 | D |
| 19 Apr 2023 18:06 | TRDA | Entrada Therapeutics Inc | SETHURAMAN NATARAJAN | Chief Scientific Officer | 17 Apr 2023 | Sale | 3,961 | 18.0045 | 71,316 | D |
| 29 Mar 2023 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Mar 2023 | Sale | 200 | 15.51 | 3,102 | D |
| 29 Mar 2023 17:12 | TRDA | Entrada Therapeutics Inc | DOSHI DIPAL | President and CEO | 27 Mar 2023 | Sale | 1,800 | 14.6296 | 26,333 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)